Methyl (2S,3S)-3-[tert-butyl(dimethyl)silyl]oxy-2-(4-chlorophenyl)pent-4-enoate
C18H27ClO3Si — CID 135054406
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl (2S,3S)-3-[tert-butyl(dimethyl)silyl]oxy-2-(4-chlorophenyl)pent-4-enoate
Methyl (2S,3S)-3-[tert-butyl(dimethyl)silyl]oxy-2-(4-chlorophenyl)pent-4-enoate (PubChem CID 135054406) has the molecular formula C18H27ClO3Si and a molecular weight of 354.95 g/mol. Its IUPAC name is methyl (2S,3S)-3-[tert-butyl(dimethyl)silyl]oxy-2-(4-chlorophenyl)pent-4-enoate.
Molecular Properties
| Compound Name | Methyl (2S,3S)-3-[tert-butyl(dimethyl)silyl]oxy-2-(4-chlorophenyl)pent-4-enoate |
|---|---|
| PubChem CID | 135054406 |
| Molecular Formula | C18H27ClO3Si |
| Molecular Weight | 354.95 g/mol |
| Exact Mass | 354.14 |
| IUPAC Name | methyl (2S,3S)-3-[tert-butyl(dimethyl)silyl]oxy-2-(4-chlorophenyl)pent-4-enoate |
| SMILES | C=C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](C(=O)OC)c1ccc(Cl)cc1 |
| InChI | InChI=1S/C18H27ClO3Si/c1-8-15(22-23(6,7)18(2,3)4)16(17(20)21-5)13-9-11-14(19)12-10-13/h8-12,15-16H,1H2,2-7H3/t15-,16-/m0/s1 |
| InChIKey | OSFVIZGSZYAOHV-HOTGVXAUSA-N |
| XLogP | 5.17 |
| TPSA | 35.53 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 354.95 |
| LogP ≤ 5 | 5.17 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135054406 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.